Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
92 Cards in this Set
- Front
- Back
Powdered Infant Formula
milk based |
Enterobacter sakazakii infection
|
|
Infection of blood and central nerve in neonates and infants
|
Enterobacter sakazakii infection
|
|
sepsis, meningities, necrotizing enterocolitis
|
Enterobacter sakazakii infection
|
|
Infants <28 days
|
Enterobacter sakazakii infection
|
|
ubiquitous
|
Enterobacter sakazakii infection
|
|
bacterium found in milk, herbs/spices, meat sausages, baby foods, vegetables
|
Enterobacter sakazakii infection
|
|
Symptoms : seizures, brain abscess, hydrocephalus, developmental delay and death
|
Enterobacter sakazakii infection
|
|
33- 80 % infant infected die
|
Enterobacter sakazakii infection
|
|
Treatment: combination of ampicillin with gentamicin or chloraamphenical
Developed resistance to ampicillin |
Enterobacter sakazakii infection
|
|
Gram -ve rod,
Enterobacteriaceae family |
Enterobacter sakazakii infection
|
|
Bacterium thermotolerant
|
Enterobacter sakazakii infection
|
|
minimum growth 6
optimal 37- 43 |
Enterobacter sakazakii infection
|
|
exact virulence unknown
|
Enterobacter sakazakii infection
|
|
bacterium could attached host cells and survive inside macrophage
|
Enterobacter sakazakii infection
|
|
Produce capsule materials
help survive environment |
Enterobacter sakazakii infection
|
|
Attached to silicon and plastic surface
|
Enterobacter sakazakii infection
|
|
Form biofilm which is difficult to remoce
|
Enterobacter sakazakii infection
|
|
Lethal dose 10^5 to 10 ^ 8 cells
|
Enterobacter sakazakii infection
|
|
contaminated during manufacturing
|
Enterobacter sakazakii infection
|
|
contaminated during infant formula preparation , eg utensil , spoon
|
Enterobacter sakazakii infection
|
|
Powdered milk is not sterilized
found in PIF 0.36- 66 CFU per 100g |
Enterobacter sakazakii infection
|
|
suitable breast milk substitue
|
accordance with the codex alimentarius commission standard
Enterobacter sakazakii infection |
|
abdominal and bowel symptoms that occur with sufficient frequency in affected patients.
|
Irritable Bowel Syndrome
|
|
symptoms : abdominal pain, bloating and bowel disturbance ( constipation or diarrhea)
|
Irritable Bowel Syndrome
|
|
etiology: multifactor
hypersensitivity stress gut microflora alteration |
Irritable Bowel Syndrome
|
|
small intestine bacterial overgrowth
|
Irritable Bowel Syndrome
|
|
increasing numbers
populations changes |
Irritable Bowel Syndrome
|
|
More Gram +ve bacteria
Bacteroides, Streptococcus, Lactobavillus |
Irritable Bowel Syndrome
|
|
Gram - ve Escherichia
|
Irritable Bowel Syndrome
|
|
Stay ill for 5 years
|
Irritable Bowel Syndrome
|
|
Treatment: Broad Spectrum antibiotics - temporary effect
|
Irritable Bowel Syndrome
|
|
Probiotic treatment:
Bifdobacterium reduced abnormal inflammation |
Irritable Bowel Syndrome
|
|
developed due to previous infectious gastroenteritis
|
Post Infection IBS
|
|
possible organisms: Camplylobacter, Salmonella, Shigella
|
Post Infection IBS
|
|
Campylobacter jejuni -stimulate infiltration of enterochromaffin (EC) and lymphocyte cells
|
Post Infection IBS
|
|
more frequent in young female
|
Post Infection IBS
|
|
Campylobacter jejun
|
stimulate infiltration of enterochromaffin (EC) and lymphocyte cells
Post Infections IBS |
|
increased gut permeability and inflammation
|
Post Infection IBS
|
|
increased EC cells, CD3 lymphocytes and macrophage IL1
|
Post Infection IBS
|
|
abnormal seretonin metabolism, increased 5- HT ( 5 hydroxytryptamine)
|
Post Infection IBS
|
|
bacterial gastroenteritis
|
Post Infection IBS
|
|
Occurs after a gastrointestinal infection with enterohemarrhagic Escherichia coli
|
Hemolytic Uremic Syndrome (HUS)
|
|
Most common in children under 5 years old
|
Hemolytic Uremic Syndrome (HUS)
|
|
Leading cause of acute renal failure in children
|
Hemolytic Uremic Syndrome (HUS)
|
|
Monitored by Foodnet
|
Hemolytic Uremic Syndrome (HUS)
|
|
Symptoms : early - vomiting, bloody diarrhea, weakness, irritability
|
Hemolytic Uremic Syndrome (HUS)
|
|
Symptoms: later- low or no urine output, Blood in urine, anemia, loss of consciousness, high blood pressure
|
Hemolytic Uremic Syndrome (HUS)
|
|
Mortality rate 5 - 15%
|
Hemolytic Uremic Syndrome (HUS)
|
|
Treatment: Dialysis
Medications such as corticosteroids |
Hemolytic Uremic Syndrome (HUS)
|
|
Transfusions of red blood cells and platelets
|
Hemolytic Uremic Syndrome (HUS)
|
|
Primary EHEC serotype is O157: H7
|
Hemolytic Uremic Syndrome (HUS)
|
|
other bacteria : salmonella shigella
other than O157 |
Hemolytic Uremic Syndrome (HUS)
|
|
Primary virulence factor is shiga toxin
|
Hemolytic Uremic Syndrome (HUS)
|
|
Shiga toxin ( stx) -ve bacteria
|
Hemolytic Uremic Syndrome (HUS)
|
|
Intimin positive ( eae+)
|
Stx negative bacteria
Hemolytic Uremic Syndrome (HUS) |
|
Stx gene may have been lost during infection mediated by bacteriophage
|
Hemolytic Uremic Syndrome (HUS)
|
|
Shiga toxin ( Stx) inhibits protein synthesis within target cells
|
Hemolytic Uremic Syndrome (HUS)
|
|
Stx could lyse blood cells - hemolytic anemia
|
Hemolytic Uremic Syndrome (HUS)
|
|
Cellular debris accumulates within the boly's tiny blood vessels
|
Hemolytic Uremic Syndrome (HUS)
|
|
Formation of micro clot in the blood vessel rich kidneys leads to impaired kidney function
|
Hemolytic Uremic Syndrome (HUS)
|
|
can cause damage to other major organs
|
Hemolytic Uremic Syndrome (HUS)
|
|
AKA reither's syndrome , post infectious arthritis
|
Reactive Arthritis ( ReA)
|
|
autoimmune disease developed after gastrointestinal and genitourinary infection
|
Reactive Arthritis ( ReA)
|
|
Symptoms: inflammation of joints ( arthritis), conjunctivitis ( eyes), skin, urinary tract ( urethritis)
|
Reactive Arthritis ( ReA)
|
|
symptoms reoccur in 50% of cases
|
Reactive Arthritis ( ReA)
|
|
Treatment: anti inflammatory and pain relieving drugs
|
Reactive Arthritis ( ReA)
|
|
Genetic factor : 60 - 85% patients are HLA B27 positive
|
Reactive Arthritis ( ReA)
|
|
What is HLA
|
Human Leukocyte antigen
Reactive Arthritis ( ReA) |
|
HLA =?
|
Human major histocompatibility complex ( MHC)
Reactive Arthritis ( ReA) |
|
cell surface molecules --> tissue typing
|
Human Leukocyte antigen
Reactive Arthritis ( ReA) |
|
help present antigen at the surface of antigen presenting cell (APC) to T cells
|
Human Leukocyte antigen
Reactive Arthritis ( ReA) |
|
B27 is?
|
Subtype of class 1 MHC , B gene
Human Leukocyte antigen Reactive Arthritis ( ReA) |
|
B27 is strongly associated with?
|
Spondyloarthritis ( including ReA)
Human Leukocyte antigen Reactive Arthritis ( ReA) |
|
which 2 factors are required to trigger ReA?
|
B27 and previous infection
Human Leukocyte antigen Reactive Arthritis ( ReA) |
|
Which previous infections are they?
|
Gastrointestinal bacteria
and genitourinary infection Human Leukocyte antigen Reactive Arthritis ( ReA) |
|
Gastrointesinal Bacteria
|
Yersinia, Camplylobacter , Salmonella, Shigella
Human Leukocyte antigen Reactive Arthritis ( ReA) |
|
Genitourinary Infection (STD)
|
chlamydia and gonorrhea
Human Leukocyte antigen Reactive Arthritis ( ReA) |
|
How a distal(2 or more) infection causes ReA?
|
Hypo 1: presence and persistence of bacterial antigens in the synovial fluid.
Human Leukocyte antigen Reactive Arthritis ( ReA) |
|
Presence of Viable but non culturable bacteria
|
Hypo 1
Human Leukocyte antigen Reactive Arthritis ( ReA) |
|
Presence of immunogenic bacterial antigens
|
such as Yersinia adhisin YadS, bind specifically to joint collagens
Human Leukocyte antigen Reactive Arthritis ( ReA) |
|
Bacterial DNA contains un-methylated CpGF motifs, stimulates monocytes
|
presence of immunogenic bacterial antigens
Human Leukocyte antigen Reactive Arthritis ( ReA) |
|
Bacterial LPS could stimulate macrophage and cytokineses
|
presence of immunogenic bacterial antigens
Human Leukocyte antigen Reactive Arthritis ( ReA) |
|
antigen mimicry leads to autoimmunity
|
Hypo 2
ReA |
|
What is best studied in Yersinia enterocolitica
T cells, stimulated by pathogen, cross react to self antigen in the joint Yersinia YopH mimics CD45 mimicry among evolutionarily conserved epitopes, hsp60 |
Hypo2
ReA |
|
autoimmune disorder affecting peripheral nerve system after gastrointestinal or respiratory infection
|
Guillain - Barre Syndrome (GBS)
|
|
One of the leading cause of acute non trauma induced paralysis in the world
|
Guillain - Barre Syndrome (GBS)
|
|
Symptoms: symmetrical weakness from the lower limbs and rapidly progresses in an ascending fashion.
|
Guillain - Barre Syndrome (GBS)
|
|
rubbery legs, drooling, difficulty swallowing, respiratory difficulty
|
Guillain - Barre Syndrome (GBS)
|
|
Treatment: Supportive care
Intravenous Immunoglobulins |
Guillain - Barre Syndrome (GBS)
|
|
What is the organisms involved in GBS
|
campylobacter jejuni
|
|
Mechanisms of GBS
|
T cells stimulate by infection --> attack ganliosides on neuron ..> loss if myelin -- > muscle paralysis
|
|
Can myelin regrow
|
Yes and patient will recover
GBS |